Cargando…
Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal
BACKGROUND: Induction chemotherapy (ICT) is supposed to reduce the risk of micrometastatic progression and improve resectability of non-small cell lung cancer (NSCLC). However, best indications for ICT strategy remain unclear in published meta-analyses. Based on this observation, an evaluation of da...
Autores principales: | Fabre, Elizabeth, Rivera, Caroline, Mordant, Pierre, Gibault, Laure, Dujon, Antoine, Foucault, Christophe, Le Pimpec-Barthes, Françoise, Riquet, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632925/ https://www.ncbi.nlm.nih.gov/pubmed/26557911 http://dx.doi.org/10.1111/1759-7714.12250 |
Ejemplares similares
-
Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer
por: Pécuchet, Nicolas, et al.
Publicado: (2015) -
Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
por: Legras, Antoine, et al.
Publicado: (2017) -
Induction of resident memory T cells enhances the efficacy of cancer vaccine
por: Nizard, Mevyn, et al.
Publicado: (2017) -
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma
por: Garinet, Simon, et al.
Publicado: (2023) -
High expression of spliced X-Box Binding Protein 1 in lung tumors is associated with cancer aggressiveness and epithelial-to-mesenchymal transition
por: Tavernier, Quentin, et al.
Publicado: (2020)